- Report
- September 2026
- 194 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 404 Pages
Global
From €5271EUR$5,850USD£4,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,469GBP
- Report
- July 2026
- 110 Pages
Global
From €4280EUR$4,750USD£3,670GBP
- Report
- October 2025
- 148 Pages
Global
From €3559EUR$3,950USD£3,052GBP
- Report
- April 2026
- 150 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- June 2026
- 160 Pages
Global
From €2522EUR$2,799USD£2,163GBP
€3153EUR$3,499USD£2,704GBP
- Report
- January 2026
- 194 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2024
- 93 Pages
Global
From €3500EUR$4,161USD£3,106GBP
- Report
- September 2026
- 50 Pages
Global
From €2388EUR$2,650USD£2,048GBP
Calcium Gluconate is a medication used to treat calcium deficiencies in patients with endocrine and metabolic disorders. It is a salt of calcium and gluconic acid, and is available in both oral and injectable forms. It is used to treat hypocalcemia, a condition in which the body does not have enough calcium, and to prevent and treat tetany, a condition in which the muscles become weak and spasm. It is also used to treat hyperphosphatemia, a condition in which the body has too much phosphate. Calcium Gluconate is also used to treat calcium-related kidney stones, and to prevent and treat osteoporosis.
Calcium Gluconate is available in a variety of forms, including tablets, capsules, and solutions. It is also available as an injectable solution, which is used to treat severe calcium deficiencies. It is available over-the-counter and by prescription.
Companies in the Calcium Gluconate market include Pfizer, Merck, Novartis, Sanofi, and Mylan. Show Less Read more